Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Health & Fitness
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/c0/5e/76/c05e760e-55a0-b5b3-9722-8dbcf60a004c/mza_6586002612235378273.png/600x600bb.jpg
HealthTree Podcast for Multiple Myeloma
HealthTree Podcast for MM
178 episodes
2 days ago
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
Show more...
Health & Fitness
RSS
All content for HealthTree Podcast for Multiple Myeloma is the property of HealthTree Podcast for MM and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
Show more...
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40464506/0957d70ad579c326.png
Alfred Garfall, MD and Bea Razzo, MD on Bispecific Antibodies in Multiple Myeloma
HealthTree Podcast for Multiple Myeloma
59 minutes 41 seconds
1 year ago
Alfred Garfall, MD and Bea Razzo, MD on Bispecific Antibodies in Multiple Myeloma

Learn how bispecific antibodies are being used in multiple myeloma care and how physicians are helping patients manage side effects using new approaches like fixed-duration therapy.

HealthTree Podcast for Multiple Myeloma
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.